ask="0.9000"
ask_size="2000"
average_daily_volume="488674"
bid="0.2026"
bid_size="500"
book_value="1.6420"
change="-0.0302"
change_from_200_day_moving_average="-0.4269"
change_from_50_day_moving_average="-0.0461"
change_from_52_week_high="-2.7392"
change_From_52_week_low="0.1305"
change_in_percent="-4.3705%"
close="0.6608"
dividend_pay_date="8/19/2015"
dividend_per_share="0.0000"
dividend_yield="0.0000"
earnings_per_share="-1.5860"
ebitda="-16.45M"
eps_estimate_current_year="-1.5200"
eps_estimate_next_quarter="-0.4100"
eps_estimate_next_year="-1.2400"
ex_dividend_date="8/20/2015"
float_shares="5445000"
high="0.6990"
high_52_weeks="3.4000"
last_trade_date="1/5/2017"
last_trade_price="0.6608"
last_trade_size="100"
last_trade_time="4:00pm"
low="0.6600"
low_52_weeks="0.5303"
market_capitalization="7.95M"
moving_average_200_day="1.0877"
moving_average_50_day="0.7069"
name="Catalyst Biosciences
Inc."
notes="N/A"
one_year_target_price="3.2500"
open="0.6600"
pe_ratio="N/A"
peg_ratio="0.0200"
percent_change_from_200_day_moving_average="-39.2468%"
percent_change_from_50_day_moving_average="-6.5181%"
percent_change_from_52_week_high="-80.5647%"
percent_change_from_52_week_low="+24.6087%"
previous_close="0.6910"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.4208"
price_per_sales="19.0159"
revenue="437000.00"
shares_outstanding="12026000"
short_ratio="0.0900"
stock_exchange="NCM"
symbol="CBIO"
volume="73819"
weeks_range_52="0.5303 - 3.4000"
